TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -7 | 4 | 7 | -25 | -41 | 0 | -12 |
| P | %wins | 0 | 100 | 100 | 0 | 0 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/23/18 16:43 | 4/23/18 | SURF | Surface Oncology, Inc. | V8 | Health | Drug | Pharmaceutical Preparations | Novartis Institutes For Biomedical Research, Inc. | MA | T | P.d | 11,500 | 15.00 | 0 | 767 | 24 | 3,948 | D | |||||||||||||||
12/14/17 12:19 | 12/12/17 | NTLA | Intellia Therapeutics, Inc. | V8 | Health | Drug | Pharmaceutical Preparations | Novartis Institutes For Biomedical Research, Inc. | MA | T | S | -27,871 | 18.30 | 0 | -1,523 | -27 | 4,130 | D | |||||||||||||||
5/11/16 18:57 | 5/11/16 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Novartis Institutes For Biomedical Research, Inc. | MA | T | P.d | 5,000 | 18.00 | 33 | 278 | 5 | 5,574 | D | -7 | 4 | 7 | -25 | -41 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |